Pulmonology Practice Questions

Q: What are the advantages of using a long-acting beta-agonist (LABA) in combination with an inhaled corticosteroid for asthma management?

Reduces frequency of rescue inhaler use. ***Reduces frequency of rescue inhaler use*** - The combination of a LABA and an inhaled corticosteroid (ICS) provides both **bronchodilation** and **anti-inflammatory effects**, leading to better symptom control and reduced need for short-acting beta-agonists (SABAs). - LABAs provide **sustained bronchodilation**, preventing bronchoconstriction over a longer period, while the ICS addresses the underlying inflammation, together leading to a significant decrease in acute symptoms. *May help in preventing long-term complications of asthma* - While improved asthma control can mitigate the risk of some long-term complications, the primary direct advantage of this combination is **symptom management** and **exacerbation prevention**, not an explicit claim of preventing all long-term sequelae. - Long-term complications, such as **airway remodeling**, can still occur in severe or poorly controlled asthma despite combination therapy, although the risk is reduced. - This is a secondary benefit rather than a primary advantage of the combination. *Minimizes systemic side effects compared to oral steroids* - While this is true (inhaled therapy does have fewer systemic effects than oral corticosteroids), it is **not a specific advantage of the LABA/ICS combination** over using ICS alone. - This benefit applies to **all inhaled corticosteroids** regardless of whether they are combined with a LABA. - The question asks specifically about advantages of the **combination therapy**, not just advantages of using inhaled versus oral corticosteroids. *May have local side effects* - This statement is true, as both LABAs and ICS can cause local side effects (e.g., **oral candidiasis** with ICS, **tremor** with LABA), but it is a **disadvantage**, not an advantage. - The question asks for the advantages, and the presence of side effects, even if mild or local, is not an argument in favor of the therapy.

Q: What is the most appropriate treatment for mild persistent asthma in adults?

Low-dose inhaled corticosteroids. ***Low-dose inhaled corticosteroids*** - **Inhaled corticosteroids (ICS)** are the cornerstone for long-term control in persistent asthma due to their potent anti-inflammatory effects. - For **mild persistent asthma**, according to GINA guidelines, low-dose ICS are the recommended initial treatment to reduce airway inflammation and prevent exacerbations [1]. *Oral corticosteroids* - **Oral corticosteroids** are typically reserved for severe asthma exacerbations or very severe persistent asthma that is unresponsive to other treatments due to their significant systemic side effects. - Their use for **mild persistent asthma** is inappropriate given the availability of safer and equally effective inhaled options. *Leukotriene receptor antagonists* - **Leukotriene receptor antagonists (LTRAs)** can be considered as an alternative or an add-on therapy for mild persistent asthma, especially in patients who cannot use ICS or have concomitant allergic rhinitis [1]. - However, they are generally less effective than ICS as monotherapy for persistent asthma control [1]. *High-dose inhaled corticosteroids* - **High-dose inhaled corticosteroids** are indicated for moderate to severe persistent asthma or for patients whose symptoms are not adequately controlled on low-to-medium doses, not for mild persistent asthma [1]. - Starting with high doses for **mild persistent asthma** increases the risk of local side effects (e.g., thrush, dysphonia) without offering significant additional benefit over low doses [1].

Q: A 45-year-old male presents with exertional dyspnea and is found to have decreased lung compliance on pulmonary function tests. Which condition is most likely?

Pulmonary fibrosis. ***Pulmonary fibrosis*** - **Pulmonary fibrosis** is characterized by the thickening and scarring of lung tissue, which directly leads to a **decrease in lung compliance** and exertional dyspnea. [1] - The scarring makes the lungs stiff and difficult to inflate, requiring more effort to breathe, especially during exertion. [1] *Chronic bronchitis* - **Chronic bronchitis** is an obstructive lung disease characterized by chronic inflammation and mucus overproduction, leading to airflow obstruction, not primarily decreased lung compliance. - While it causes dyspnea, the primary physiological change is increased airway resistance rather than reduced elasticity of the lung parenchyma. *Asthma* - **Asthma** is an obstructive lung disease characterized by reversible airway hyperresponsiveness and bronchoconstriction, which affects airflow due to smooth muscle spasm and inflammation. [2] - It increases airway resistance but does not primarily cause a decrease in lung compliance, which relates to the stiffness of the lung tissue itself. [2] *Emphysema* - **Emphysema** is an obstructive lung disease characterized by the destruction of alveolar walls, leading to enlarged airspaces and a **loss of elastic recoil**, which actually *increases* lung compliance. [1] - This condition makes exhalation difficult rather than inhalation due to reduced elastic recoil, the opposite of decreased lung compliance.

Q: Which medication is considered the first-line treatment for long-term management of asthma?

Inhaled corticosteroids are the first-line treatment.. ***Inhaled corticosteroids are the first-line treatment.*** - **Inhaled corticosteroids (ICS)** are the cornerstone of long-term asthma therapy due to their potent **anti-inflammatory effects** on the airways [1, 2]. - They reduce **airway hyperresponsiveness**, prevent exacerbations, and improve lung function by targeting the underlying inflammation of asthma [1].*Combination therapy is the first-line treatment.* - **Combination therapy**, typically involving an ICS and a **long-acting beta-agonist (LABA)**, is reserved for patients whose asthma is not well-controlled with ICS alone [1]. - While highly effective, it is a step-up therapy rather than the initial first-line approach for most newly diagnosed or mild asthmatics [1].*Long-acting beta agonists are the first-line treatment.* - **Long-acting beta-agonists (LABAs)** are bronchodilators that provide prolonged relief of bronchoconstriction but do not address airway inflammation [2]. - They should **never be used as monotherapy** in asthma due to the risk of masking inflammation and potentially increasing adverse events [1].*None of the options is the first-line treatment.* - This statement is incorrect as **inhaled corticosteroids** are indeed recognized as the primary first-line treatment for long-term asthma management [1, 2]. - Major asthma guidelines consistently recommend ICS as the initial and foundational therapy [1, 2].

Q: A 50-year-old male smoker with a history of chronic cough develops sudden dyspnea, chest pain, and a sense of impending doom. A chest X-ray shows a large right-sided pleural effusion. What is the most likely diagnosis?

Pulmonary embolism. ***Pulmonary embolism*** - The combination of **sudden dyspnea**, **chest pain**, and a **sense of impending doom** is classic for a pulmonary embolism, particularly in a patient with risk factors like smoking [1]. - The presence of a **large right-sided pleural effusion** on the chest X-ray may indicate **effusion due to congestive heart failure** associated with right heart strain from the embolism. *Spontaneous pneumothorax* - Characterized by **sudden onset of chest pain** and dyspnea, but typically does not include a sense of impending doom or pleural effusions [2]. - Chest X-ray would show **collapsed lung** rather than a large pleural effusion [2]. *Acute asthma attack* - Usually presents with **wheezing** and prolonged expiration, not typically associated with severe sharp chest pain or a pleural effusion. - Sudden dyspnea is present, but the clinical picture does not match this acute respiratory event. *Pneumonia* - Typically presents with **fever, cough, and pleuritic chest pain**, and is less likely to cause a sudden onset of dyspnea and feelings of impending doom [1]. - Chest X-ray may demonstrate **consolidation** rather than a large pleural effusion, which is more suggestive of pulmonary embolism since effusions can occur secondarily [1].

Q: A 27-year-old male with a history of asthma presents with wheezing and shortness of breath that is unresponsive to albuterol. What is the next best step in management?

Administer IV corticosteroids. ***Administer IV corticosteroids*** - In a patient with **acute asthma exacerbation** unresponsive to **albuterol**, systemic corticosteroids are crucial to reduce airway inflammation [1]. - **IV corticosteroids** have a relatively quick onset of action and can prevent disease progression and future exacerbations [1]. *Increase albuterol dosage* - While **albuterol** is a first-line bronchodilator, increasing its dosage alone is insufficient if the patient is already unresponsive, indicating significant **airway inflammation** [1]. - Continued or increased albuterol without addressing inflammation may not provide adequate relief and can lead to **tachycardia** or **tremors** [1]. *Administer oral theophylline* - **Theophylline** is a less common and **second-line bronchodilator** with a narrow therapeutic window and potential for significant side effects [3]. - It is typically not used in acute exacerbations due to its slow onset and monitoring requirements, especially when other more effective therapies are available [3]. *Start long-acting beta agonist* - **Long-acting beta agonists (LABAs)** are used as **controller medications** for chronic asthma management, not for acute exacerbations [2]. - Adding a LABA during an acute attack would not address the immediate airway constriction and inflammation effectively and can even be dangerous if used without an **inhaled corticosteroid** [2].

Q: A 60-year-old man with chronic obstructive pulmonary disease presents with a COPD exacerbation. What is the best initial pharmacological treatment?

Oral corticosteroids. ### Oral corticosteroids - **Oral corticosteroids** are the cornerstone of treatment for COPD exacerbations, effectively reducing **inflammation** in the airways [2]. - They improve **lung function** and shorten recovery time by decreasing airway edema and mucus production [2]. ### Antibiotics - **Antibiotics** are typically reserved for patients with signs of **bacterial infection**, such as increased sputum purulence, volume, or fever. - They are not the universal initial treatment for all COPD exacerbations, as many are viral or non-infectious. ### Inhaled corticosteroids - **Inhaled corticosteroids** are primarily used for *maintenance therapy* in moderate to severe COPD to reduce exacerbation frequency [3]. - They are not potent enough for the acute management of a **COPD exacerbation** itself [2]. ### Beta-agonists - **Beta-agonists** (bronchodilators) are crucial for *symptomatic relief* during an exacerbation by opening airways [1]. - While important, they do not address the underlying **inflammation** to the same extent as corticosteroids and are often used in conjunction rather than as the sole initial treatment [1][2].

Q: What is the first-line treatment for the acute exacerbation of chronic obstructive pulmonary disease (COPD)?

Bronchodilators. ***Bronchodilators*** - **Short-acting bronchodilators**, specifically **beta-2 agonists** (SABAs) and **short-acting muscarinic antagonists** (SAMAs), are the cornerstone of initial treatment for **COPD exacerbations** [1]. - They rapidly open airways by relaxing bronchial smooth muscles, leading to immediate symptom relief. *Inhaled corticosteroids* - While used in chronic COPD management, **inhaled corticosteroids** are typically not the primary first-line treatment for acute exacerbations alone, though they may be added to bronchodilators in some cases. - Their effect is not as rapid as bronchodilators, and systemic corticosteroids are often preferred for acute exacerbations when anti-inflammatory action is needed. *Antibiotics* - **Antibiotics** are indicated when there are signs of **bacterial infection**, such as increased sputum purulence, volume, or dyspnea, in combination with other treatments. - They are not universally recommended for all COPD exacerbations, as many are viral or non-infectious in origin. *Oxygen therapy* - **Oxygen therapy** is crucial for patients experiencing **hypoxemia** during a COPD exacerbation [2]. - However, oxygen itself does not address the underlying **bronchoconstriction** and is used as supportive care rather than a primary bronchodilating agent.

Question 1

What are the advantages of using a long-acting beta-agonist (LABA) in combination with an inhaled corticosteroid for asthma management?

Accepted Answer

Reduces frequency of rescue inhaler use

Answer

May help in preventing long-term complications of asthma

Answer

May have local side effects

Answer

Minimizes systemic side effects compared to oral steroids

Question 2

What is the most appropriate treatment for mild persistent asthma in adults?

Accepted Answer

Low-dose inhaled corticosteroids

Answer

Oral corticosteroids

Answer

Leukotriene receptor antagonists

Answer

High-dose inhaled corticosteroids

Question 3

A 45-year-old male presents with exertional dyspnea and is found to have decreased lung compliance on pulmonary function tests. Which condition is most likely?

Accepted Answer

Pulmonary fibrosis

Answer

Chronic bronchitis

Answer

Asthma

Answer

Emphysema

Question 4

A 68-year-old male with a history of smoking presents with hemoptysis and weight loss. A chest X-ray shows a mass in the upper lobe, and laboratory results indicate hypercalcemia. Analyze and determine the diagnosis and initial treatment.

Accepted Answer

Squamous cell carcinoma; initial management includes bronchoscopy and biopsy

Answer

Tuberculosis; initial management includes sputum acid-fast bacilli test

Answer

COPD exacerbation; initial management includes bronchodilators and steroids

Answer

Pulmonary embolism; initial management includes CT angiography

Question 5

Which medication is considered the first-line treatment for long-term management of asthma?

Accepted Answer

Inhaled corticosteroids are the first-line treatment.

Answer

Combination therapy is the first-line treatment.

Answer

Long-acting beta agonists are the first-line treatment.

Answer

None of the options is the first-line treatment.

Question 6

A 50-year-old male smoker with a history of chronic cough develops sudden dyspnea, chest pain, and a sense of impending doom. A chest X-ray shows a large right-sided pleural effusion. What is the most likely diagnosis?

Accepted Answer

Pulmonary embolism

Answer

Pneumonia

Answer

Acute asthma attack

Answer

Spontaneous pneumothorax

Question 7

A 27-year-old male with a history of asthma presents with wheezing and shortness of breath that is unresponsive to albuterol. What is the next best step in management?

Accepted Answer

Administer IV corticosteroids

Answer

Increase albuterol dosage

Answer

Administer oral theophylline

Answer

Start long-acting beta agonist

Question 8

A 60-year-old man with chronic obstructive pulmonary disease presents with a COPD exacerbation. What is the best initial pharmacological treatment?

Accepted Answer

Oral corticosteroids

Answer

Antibiotics

Answer

Inhaled corticosteroids

Answer

Beta-agonists

Question 9

What is the first-line treatment for the acute exacerbation of chronic obstructive pulmonary disease (COPD)?

Accepted Answer

Bronchodilators

Answer

Inhaled corticosteroids

Answer

Antibiotics

Answer

Oxygen therapy

Question 10

A 72-year-old male with COPD presents with increased shortness of breath, wheezing, and a productive cough. Vital signs show BP 150/90, HR 110, RR 28, and O2 saturation at 88% on room air. Examination reveals decreased breath sounds bilaterally, wheezes, and use of accessory muscles. Laboratory results indicate increased pCO2, increased HCO3, and decreased pH. Analyze and determine the most appropriate next step in management.

Accepted Answer

BiPAP and nebulized bronchodilators for ventilation support

Answer

Intubation and mechanical ventilation for severe respiratory failure

Answer

High-flow oxygen and corticosteroids for respiratory support

Answer

Oral antibiotics and albuterol inhaler for acute management

Pulmonology — MCQs

Pulmonology — MCQs

On this page

Practice by Chapter

Want unlimited practice?